Providers could spend more than a million more hours collecting and submitting data annually to comply with proposals in the ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

According to the notice issued by NBEMS, NEET MDS 2026 will be conducted in computer-based mode at designated examination centres across the country. The board has also advised applicants to carefully ...

The National Board of Examinations in Medical Sciences (NBEMS) has started the registration process for the NEET MDS 2026 on the official website. Interested candidates will be able to register for ...

NEET MDS 2026 Application Form (OUT): The deadline for submitting the application form is March 30, 2026. NEET MDS 2026 Application Form (OUT): The National Board of Examinations in Medical Sciences ...

The National Board of Examinations in Medical Sciences, NBEMS, has begun the registration process for the NEET MDS 2026 examination. Candidates seeking admission to the Master of Dental Surgery (MDS) ...

NBEMS has officially opened the online application window for the National Eligibility Cum Entrance Test for Master of Dental Surgery (NEET MDS) 2026 today, March 14. Eligible candidates who wish to ...

Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...

“The success of the SELECT-MDS-1 trial was as an efficiently accrued international phase 3 trial that was biomarker driven, the first of its kind in MDS. Although the doublet combination tested in ...

Malaysian state energy firm Petronas said on Wednesday that it remains committed to meeting its contractual obligations and maintaining reliable gas supply for buyers following a Court of Appeal ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...